DVYSR (DVYSR) News
Follow DVYSR (DVYSR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Devyser Diagnostics Q3 2026 Earnings Call Begins
Devyser Diagnostics' quarterly earnings call has begun.
EQUITY | Nov 03, 2026, 07:58 AM UTC
M
Devyser Reports Q3 Sales Drag and Improved Profitability
The largest distributor’s inventory adjustment weighed on Q3 sales and is expected to affect Q4; sales are expected to gradually normalize from 2027. Profitability improved year over year in Q3 and January–September.
EARNINGS | Nov 03, 2026, 06:30 AM UTC
M
Devyser Wins SEK 5.7M Milan Tender, Doubling Test Volumes
Devyser won a renewed three-year tender with Milan’s IRCCS Ca' Granda Policlinico for Devyser Thalassemia and Amplicon Suite. The tender is valued at about SEK 5.7 million and runs from 1 September 2026 to 31 August 2029
EQUITY | Oct 21, 2026, 12:01 PM UTC
L
Devyser appoints Torben Thölix as Chief Commercial Officer
Devyser appointed Torben Thölix as its new Chief Commercial Officer.
EQUITY | Aug 31, 2026, 08:00 AM UTC